Baricitinib as monotherapy and with topical corticosteroids in moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of dose-response

Baricitinib as monotherapy and with topical corticosteroids in moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of dose-response

IntroductionAtopic dermatitis (AD) is a chronic inflammatory skin disorder that affects millions worldwide, presenting challenges in managing symptoms and quality of life. Current treatments include topical corticosteroids (TCS), but novel approaches, such as Janus kinase (JAK) inhibitors, show prom...

Full description

Saved in:
Bibliographic Details
Main Authors: Ibrahim H. I. Almoghayer, Abdul Mateen Soomro, Shah Dev, Muskan Turesh, Ateesh Kumar, Ravi Kumar, Aashish Meghjiani, Syeda Lamiya Mir, Muhammad Hassaan, Rehan Qureshi, Vishal Kumar, Taimoor Ashraf, F. N. U. Deepak, Mohammad Arham Siddiq, Abdul Haseeb, Ayush Kumar
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Allergy
Subjects:
atopic dermatitis
baricitinib
JAK inhibitors
eczema area and severity index
treatment-emergent adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2024.1486271/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2024.1486271/full

Similar Items